nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—RET—parathyroid gland—nephrolithiasis	0.0542	0.101	CbGeAlD
Regorafenib—UGT1A1—urine—nephrolithiasis	0.0333	0.0623	CbGeAlD
Regorafenib—FRK—renal system—nephrolithiasis	0.0215	0.0401	CbGeAlD
Regorafenib—CYP2C19—urine—nephrolithiasis	0.0181	0.0337	CbGeAlD
Regorafenib—EPHX2—nephron tubule—nephrolithiasis	0.0143	0.0267	CbGeAlD
Regorafenib—CYP2C9—urine—nephrolithiasis	0.014	0.0262	CbGeAlD
Regorafenib—EPHX2—cortex of kidney—nephrolithiasis	0.0123	0.0229	CbGeAlD
Regorafenib—UGT1A9—renal system—nephrolithiasis	0.0119	0.0222	CbGeAlD
Regorafenib—UGT1A9—kidney—nephrolithiasis	0.0115	0.0215	CbGeAlD
Regorafenib—FLT4—cortex of kidney—nephrolithiasis	0.0111	0.0206	CbGeAlD
Regorafenib—FGFR1—cortex of kidney—nephrolithiasis	0.0109	0.0204	CbGeAlD
Regorafenib—CYP3A4—urine—nephrolithiasis	0.0107	0.02	CbGeAlD
Regorafenib—EPHA2—nephron tubule—nephrolithiasis	0.0106	0.0199	CbGeAlD
Regorafenib—RET—renal system—nephrolithiasis	0.0104	0.0193	CbGeAlD
Regorafenib—FLT1—nephron tubule—nephrolithiasis	0.01	0.0187	CbGeAlD
Regorafenib—RET—kidney—nephrolithiasis	0.01	0.0187	CbGeAlD
Regorafenib—RAF1—nephron tubule—nephrolithiasis	0.00998	0.0186	CbGeAlD
Regorafenib—FGFR2—renal system—nephrolithiasis	0.00985	0.0184	CbGeAlD
Regorafenib—FGFR2—kidney—nephrolithiasis	0.00952	0.0178	CbGeAlD
Regorafenib—TEK—renal system—nephrolithiasis	0.00944	0.0176	CbGeAlD
Regorafenib—FLT1—renal system—nephrolithiasis	0.00913	0.017	CbGeAlD
Regorafenib—TEK—kidney—nephrolithiasis	0.00913	0.017	CbGeAlD
Regorafenib—RAF1—renal system—nephrolithiasis	0.00907	0.0169	CbGeAlD
Regorafenib—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00903	0.0633	CcSEcCtD
Regorafenib—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00897	0.0629	CcSEcCtD
Regorafenib—TEK—cortex of kidney—nephrolithiasis	0.00889	0.0166	CbGeAlD
Regorafenib—FLT1—kidney—nephrolithiasis	0.00882	0.0165	CbGeAlD
Regorafenib—RAF1—kidney—nephrolithiasis	0.00877	0.0164	CbGeAlD
Regorafenib—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00874	0.0612	CcSEcCtD
Regorafenib—FLT1—cortex of kidney—nephrolithiasis	0.00859	0.016	CbGeAlD
Regorafenib—PDGFRA—renal system—nephrolithiasis	0.00855	0.016	CbGeAlD
Regorafenib—RAF1—cortex of kidney—nephrolithiasis	0.00854	0.0159	CbGeAlD
Regorafenib—KDR—nephron tubule—nephrolithiasis	0.00849	0.0158	CbGeAlD
Regorafenib—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00825	0.0578	CcSEcCtD
Regorafenib—UGT1A1—renal system—nephrolithiasis	0.00816	0.0152	CbGeAlD
Regorafenib—UGT1A1—kidney—nephrolithiasis	0.00789	0.0147	CbGeAlD
Regorafenib—KDR—renal system—nephrolithiasis	0.00772	0.0144	CbGeAlD
Regorafenib—KIT—nephron tubule—nephrolithiasis	0.00752	0.014	CbGeAlD
Regorafenib—KDR—kidney—nephrolithiasis	0.00746	0.0139	CbGeAlD
Regorafenib—KDR—cortex of kidney—nephrolithiasis	0.00726	0.0136	CbGeAlD
Regorafenib—KIT—renal system—nephrolithiasis	0.00684	0.0128	CbGeAlD
Regorafenib—PDGFRB—renal system—nephrolithiasis	0.00668	0.0125	CbGeAlD
Regorafenib—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00664	0.0465	CcSEcCtD
Regorafenib—KIT—kidney—nephrolithiasis	0.00661	0.0123	CbGeAlD
Regorafenib—ABL1—nephron tubule—nephrolithiasis	0.00655	0.0122	CbGeAlD
Regorafenib—PDGFRB—kidney—nephrolithiasis	0.00646	0.0121	CbGeAlD
Regorafenib—KIT—cortex of kidney—nephrolithiasis	0.00644	0.012	CbGeAlD
Regorafenib—PDGFRB—cortex of kidney—nephrolithiasis	0.00629	0.0117	CbGeAlD
Regorafenib—ABL1—renal system—nephrolithiasis	0.00595	0.0111	CbGeAlD
Regorafenib—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00591	0.0414	CcSEcCtD
Regorafenib—ABL1—kidney—nephrolithiasis	0.00575	0.0107	CbGeAlD
Regorafenib—ABL1—cortex of kidney—nephrolithiasis	0.0056	0.0105	CbGeAlD
Regorafenib—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00539	0.0378	CcSEcCtD
Regorafenib—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00535	0.0375	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0053	0.0371	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0053	0.0371	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00519	0.0364	CcSEcCtD
Regorafenib—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00475	0.0333	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00449	0.0315	CcSEcCtD
Regorafenib—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00447	0.0313	CcSEcCtD
Regorafenib—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00444	0.0311	CcSEcCtD
Regorafenib—ABCG2—nephron tubule—nephrolithiasis	0.00413	0.00771	CbGeAlD
Regorafenib—CYP2C8—renal system—nephrolithiasis	0.00386	0.00721	CbGeAlD
Regorafenib—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00385	0.027	CcSEcCtD
Regorafenib—CYP2B6—nephron tubule—nephrolithiasis	0.00381	0.00711	CbGeAlD
Regorafenib—CYP2C8—kidney—nephrolithiasis	0.00373	0.00697	CbGeAlD
Regorafenib—FGFR1—Endochondral Ossification—PTH—nephrolithiasis	0.00366	0.0114	CbGpPWpGaD
Regorafenib—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0036	0.0252	CcSEcCtD
Regorafenib—CYP2B6—renal system—nephrolithiasis	0.00346	0.00646	CbGeAlD
Regorafenib—FGFR1—Signaling by Insulin receptor—ATP6V0A4—nephrolithiasis	0.00344	0.0107	CbGpPWpGaD
Regorafenib—KDR—Beta3 integrin cell surface interactions—SPP1—nephrolithiasis	0.00343	0.0107	CbGpPWpGaD
Regorafenib—CYP2B6—kidney—nephrolithiasis	0.00335	0.00625	CbGeAlD
Regorafenib—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00332	0.0233	CcSEcCtD
Regorafenib—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00327	0.0229	CcSEcCtD
Regorafenib—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00317	0.0222	CcSEcCtD
Regorafenib—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00295	0.0207	CcSEcCtD
Regorafenib—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00283	0.0198	CcSEcCtD
Regorafenib—RAF1—Signaling by Insulin receptor—ATP6V0A4—nephrolithiasis	0.00275	0.00856	CbGpPWpGaD
Regorafenib—UGT1A1—NRF2 pathway—SLC2A9—nephrolithiasis	0.00264	0.00821	CbGpPWpGaD
Regorafenib—UGT1A9—NRF2 pathway—SLC2A9—nephrolithiasis	0.00264	0.00821	CbGpPWpGaD
Regorafenib—CYP3A4—renal system—nephrolithiasis	0.00261	0.00488	CbGeAlD
Regorafenib—CYP3A4—kidney—nephrolithiasis	0.00253	0.00472	CbGeAlD
Regorafenib—KDR—Integrins in angiogenesis—SPP1—nephrolithiasis	0.00253	0.00786	CbGpPWpGaD
Regorafenib—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00251	0.0176	CcSEcCtD
Regorafenib—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00249	0.0175	CcSEcCtD
Regorafenib—Pain—Hydrochlorothiazide—nephrolithiasis	0.00247	0.0173	CcSEcCtD
Regorafenib—KDR—Integrin cell surface interactions—SPP1—nephrolithiasis	0.00244	0.00757	CbGpPWpGaD
Regorafenib—TEK—Hemostasis—SLC7A9—nephrolithiasis	0.0024	0.00746	CbGpPWpGaD
Regorafenib—TEK—Hemostasis—DGKH—nephrolithiasis	0.0024	0.00746	CbGpPWpGaD
Regorafenib—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00236	0.0166	CcSEcCtD
Regorafenib—BRAF—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00236	0.00732	CbGpPWpGaD
Regorafenib—UGT1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00232	0.00721	CbGpPWpGaD
Regorafenib—UGT1A9—Biological oxidations—SLC26A1—nephrolithiasis	0.00232	0.00721	CbGpPWpGaD
Regorafenib—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00229	0.016	CcSEcCtD
Regorafenib—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00229	0.016	CcSEcCtD
Regorafenib—PDGFRB—Beta3 integrin cell surface interactions—SPP1—nephrolithiasis	0.00227	0.00705	CbGpPWpGaD
Regorafenib—FGFR2—FGF signaling pathway—SPP1—nephrolithiasis	0.00226	0.00702	CbGpPWpGaD
Regorafenib—FGFR2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00218	0.00679	CbGpPWpGaD
Regorafenib—FGFR1—FGF signaling pathway—SPP1—nephrolithiasis	0.0021	0.00654	CbGpPWpGaD
Regorafenib—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00207	0.0145	CcSEcCtD
Regorafenib—ABCB1—nephron tubule—nephrolithiasis	0.00204	0.0038	CbGeAlD
Regorafenib—FGFR1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00203	0.00633	CbGpPWpGaD
Regorafenib—PDGFRA—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00203	0.00631	CbGpPWpGaD
Regorafenib—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00198	0.0139	CcSEcCtD
Regorafenib—EPHA2—Direct p53 effectors—SPP1—nephrolithiasis	0.00189	0.00589	CbGpPWpGaD
Regorafenib—ABCB1—renal system—nephrolithiasis	0.00185	0.00346	CbGeAlD
Regorafenib—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00184	0.0129	CcSEcCtD
Regorafenib—FGFR1—Endochondral Ossification—SPP1—nephrolithiasis	0.00184	0.00571	CbGpPWpGaD
Regorafenib—PDGFRB—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00183	0.00568	CbGpPWpGaD
Regorafenib—Rash—Hydrochlorothiazide—nephrolithiasis	0.00182	0.0128	CcSEcCtD
Regorafenib—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00182	0.0128	CcSEcCtD
Regorafenib—Headache—Hydrochlorothiazide—nephrolithiasis	0.00181	0.0127	CcSEcCtD
Regorafenib—ABCB1—kidney—nephrolithiasis	0.00179	0.00334	CbGeAlD
Regorafenib—EPHX2—Metabolism—GRHPR—nephrolithiasis	0.00177	0.0055	CbGpPWpGaD
Regorafenib—ABCB1—cortex of kidney—nephrolithiasis	0.00174	0.00325	CbGeAlD
Regorafenib—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00172	0.012	CcSEcCtD
Regorafenib—FLT4—Signaling Pathways—ADCY10—nephrolithiasis	0.00171	0.00532	CbGpPWpGaD
Regorafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00168	0.00523	CbGpPWpGaD
Regorafenib—RAF1—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00164	0.00511	CbGpPWpGaD
Regorafenib—RAF1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00163	0.00507	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—AGXT—nephrolithiasis	0.00158	0.0049	CbGpPWpGaD
Regorafenib—FLT1—Focal Adhesion—SPP1—nephrolithiasis	0.00157	0.00488	CbGpPWpGaD
Regorafenib—MAPK11—Toll-like Receptor Signaling Pathway—SPP1—nephrolithiasis	0.00148	0.0046	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—RGS14—nephrolithiasis	0.00145	0.00452	CbGpPWpGaD
Regorafenib—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	0.00144	0.00448	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00143	0.00446	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00143	0.00446	CbGpPWpGaD
Regorafenib—NTRK1—BDNF signaling pathway—SPP1—nephrolithiasis	0.00138	0.00429	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—SLC26A1—nephrolithiasis	0.00134	0.00416	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—APRT—nephrolithiasis	0.00134	0.00416	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00128	0.00397	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—ADCY10—nephrolithiasis	0.00128	0.00397	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00125	0.00389	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00125	0.00389	CbGpPWpGaD
Regorafenib—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.00122	0.00379	CbGpPWpGaD
Regorafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00122	0.00378	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00117	0.00363	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00117	0.00363	CbGpPWpGaD
Regorafenib—MAPK11—Regulation of toll-like receptor signaling pathway—SPP1—nephrolithiasis	0.00115	0.00359	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00111	0.00346	CbGpPWpGaD
Regorafenib—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.00109	0.00339	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—RGS14—nephrolithiasis	0.00108	0.00337	CbGpPWpGaD
Regorafenib—KDR—Focal Adhesion—SPP1—nephrolithiasis	0.00105	0.00325	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00102	0.00317	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00102	0.00317	CbGpPWpGaD
Regorafenib—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000993	0.00309	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—DGKH—nephrolithiasis	0.000982	0.00305	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000982	0.00305	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—AQP1—nephrolithiasis	0.000954	0.00297	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—SLC7A9—nephrolithiasis	0.000927	0.00288	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—DGKH—nephrolithiasis	0.000927	0.00288	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—ADCY10—nephrolithiasis	0.000898	0.00279	CbGpPWpGaD
Regorafenib—BRAF—Focal Adhesion—SPP1—nephrolithiasis	0.00089	0.00277	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000885	0.00275	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000885	0.00275	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—CHRM3—nephrolithiasis	0.000863	0.00268	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by PDGF—SPP1—nephrolithiasis	0.000854	0.00266	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—ADCY10—nephrolithiasis	0.000849	0.00264	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—SLC7A9—nephrolithiasis	0.000848	0.00263	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—DGKH—nephrolithiasis	0.000848	0.00263	CbGpPWpGaD
Regorafenib—KIT—Signaling by PDGF—SPP1—nephrolithiasis	0.000839	0.00261	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000823	0.00256	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000823	0.00256	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—SPP1—nephrolithiasis	0.000803	0.0025	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by PDGF—SPP1—nephrolithiasis	0.000796	0.00247	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by PDGF—SPP1—nephrolithiasis	0.000794	0.00247	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000772	0.0024	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000772	0.0024	CbGpPWpGaD
Regorafenib—RAF1—BDNF signaling pathway—SPP1—nephrolithiasis	0.000769	0.00239	CbGpPWpGaD
Regorafenib—PDGFRA—Focal Adhesion—SPP1—nephrolithiasis	0.000767	0.00238	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—RGS14—nephrolithiasis	0.000764	0.00237	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000734	0.00228	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000734	0.00228	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—DGKH—nephrolithiasis	0.000733	0.00228	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000733	0.00228	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—ADCY10—nephrolithiasis	0.00073	0.00227	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—ADCY10—nephrolithiasis	0.000723	0.00225	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—RGS14—nephrolithiasis	0.000722	0.00224	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—RGS14—nephrolithiasis	0.00072	0.00224	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000718	0.00223	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000718	0.00223	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by PDGF—SPP1—nephrolithiasis	0.000715	0.00222	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—CHRM3—nephrolithiasis	0.00071	0.00221	CbGpPWpGaD
Regorafenib—PDGFRB—Focal Adhesion—SPP1—nephrolithiasis	0.000691	0.00215	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000676	0.0021	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000676	0.0021	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—ADCY10—nephrolithiasis	0.00067	0.00208	CbGpPWpGaD
Regorafenib—BRAF—Disease—SLC26A1—nephrolithiasis	0.000665	0.00207	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—ADCY10—nephrolithiasis	0.000658	0.00205	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000655	0.00204	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—PTH—nephrolithiasis	0.000649	0.00202	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00064	0.00199	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00064	0.00199	CbGpPWpGaD
Regorafenib—RAF1—Signaling by PDGF—SPP1—nephrolithiasis	0.000638	0.00198	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—ADCY10—nephrolithiasis	0.000625	0.00194	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—ADCY10—nephrolithiasis	0.000623	0.00194	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—RGS14—nephrolithiasis	0.000621	0.00193	CbGpPWpGaD
Regorafenib—FGFR2—Disease—SLC26A1—nephrolithiasis	0.000617	0.00192	CbGpPWpGaD
Regorafenib—RAF1—Focal Adhesion—SPP1—nephrolithiasis	0.000616	0.00192	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—RGS14—nephrolithiasis	0.000615	0.00191	CbGpPWpGaD
Regorafenib—KIT—Disease—SLC26A1—nephrolithiasis	0.000606	0.00188	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000602	0.00187	CbGpPWpGaD
Regorafenib—BRAF—Disease—ATP6V0A4—nephrolithiasis	0.000593	0.00184	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000587	0.00182	CbGpPWpGaD
Regorafenib—FGFR1—Disease—SLC26A1—nephrolithiasis	0.000575	0.00179	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—SLC26A1—nephrolithiasis	0.000573	0.00178	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—RGS14—nephrolithiasis	0.00057	0.00177	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—ADCY10—nephrolithiasis	0.000561	0.00175	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—RGS14—nephrolithiasis	0.00056	0.00174	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000551	0.00171	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000551	0.00171	CbGpPWpGaD
Regorafenib—FGFR2—Disease—ATP6V0A4—nephrolithiasis	0.00055	0.00171	CbGpPWpGaD
Regorafenib—KIT—Disease—ATP6V0A4—nephrolithiasis	0.00054	0.00168	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—RGS14—nephrolithiasis	0.000531	0.00165	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—RGS14—nephrolithiasis	0.00053	0.00165	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—CHRM3—nephrolithiasis	0.00053	0.00165	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—GRHPR—nephrolithiasis	0.000523	0.00163	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—GRHPR—nephrolithiasis	0.000523	0.00163	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—SLC26A1—nephrolithiasis	0.000516	0.00161	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000516	0.0016	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—DGKH—nephrolithiasis	0.000516	0.0016	CbGpPWpGaD
Regorafenib—FGFR1—Disease—ATP6V0A4—nephrolithiasis	0.000512	0.00159	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000512	0.00159	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—ATP6V0A4—nephrolithiasis	0.000511	0.00159	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—ADCY10—nephrolithiasis	0.0005	0.00156	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—DGKH—nephrolithiasis	0.000488	0.00152	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000488	0.00152	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—DGKH—nephrolithiasis	0.000486	0.00151	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—PTH—nephrolithiasis	0.000485	0.00151	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—RGS14—nephrolithiasis	0.000477	0.00148	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—AGXT—nephrolithiasis	0.000466	0.00145	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—AGXT—nephrolithiasis	0.000466	0.00145	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—ATP6V0A4—nephrolithiasis	0.00046	0.00143	CbGpPWpGaD
Regorafenib—RAF1—Disease—SLC26A1—nephrolithiasis	0.00046	0.00143	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000444	0.00138	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—RGS14—nephrolithiasis	0.000425	0.00132	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000419	0.0013	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—DGKH—nephrolithiasis	0.000419	0.0013	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000418	0.0013	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000418	0.0013	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000415	0.00129	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—DGKH—nephrolithiasis	0.000415	0.00129	CbGpPWpGaD
Regorafenib—RAF1—Disease—ATP6V0A4—nephrolithiasis	0.00041	0.00128	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—APRT—nephrolithiasis	0.000396	0.00123	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—SLC26A1—nephrolithiasis	0.000396	0.00123	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—SLC26A1—nephrolithiasis	0.000396	0.00123	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—APRT—nephrolithiasis	0.000396	0.00123	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000395	0.00123	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000388	0.00121	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000388	0.00121	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—DGKH—nephrolithiasis	0.000385	0.0012	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000385	0.0012	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000378	0.00118	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—DGKH—nephrolithiasis	0.000378	0.00118	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CHRM3—nephrolithiasis	0.000373	0.00116	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—DGKH—nephrolithiasis	0.000359	0.00112	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000359	0.00112	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—DGKH—nephrolithiasis	0.000358	0.00111	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000358	0.00111	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CHRM3—nephrolithiasis	0.000352	0.0011	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000352	0.00109	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000346	0.00108	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000346	0.00108	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PTH—nephrolithiasis	0.000341	0.00106	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000336	0.00105	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—APRT—nephrolithiasis	0.000336	0.00105	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—SPP1—nephrolithiasis	0.000326	0.00101	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GRHPR—nephrolithiasis	0.000325	0.00101	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DGKH—nephrolithiasis	0.000322	0.001	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000322	0.001	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PTH—nephrolithiasis	0.000322	0.001	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—PTH—nephrolithiasis	0.000322	0.001	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CHRM3—nephrolithiasis	0.000303	0.000942	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CHRM3—nephrolithiasis	0.0003	0.000933	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—AGXT—nephrolithiasis	0.00029	0.000901	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000287	0.000893	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DGKH—nephrolithiasis	0.000287	0.000893	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—AQP1—nephrolithiasis	0.000282	0.000878	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—AQP1—nephrolithiasis	0.000282	0.000878	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CHRM3—nephrolithiasis	0.000278	0.000865	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PTH—nephrolithiasis	0.000277	0.000862	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000277	0.00086	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000275	0.000856	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PTH—nephrolithiasis	0.000275	0.000854	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CHRM3—nephrolithiasis	0.000273	0.00085	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CHRM3—nephrolithiasis	0.000259	0.000806	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CHRM3—nephrolithiasis	0.000259	0.000804	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CHRM3—nephrolithiasis	0.000255	0.000794	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CHRM3—nephrolithiasis	0.000255	0.000794	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PTH—nephrolithiasis	0.000255	0.000791	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PTH—nephrolithiasis	0.00025	0.000777	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—APRT—nephrolithiasis	0.000246	0.000766	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	0.000246	0.000766	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000246	0.000764	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000245	0.000763	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—SPP1—nephrolithiasis	0.000243	0.000756	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.00024	0.000746	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—AQP1—nephrolithiasis	0.00024	0.000745	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PTH—nephrolithiasis	0.000237	0.000738	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PTH—nephrolithiasis	0.000237	0.000736	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CHRM3—nephrolithiasis	0.000233	0.000725	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000224	0.000697	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000219	0.000681	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000217	0.000674	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000214	0.000665	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PTH—nephrolithiasis	0.000213	0.000663	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000209	0.000649	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000209	0.000649	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CHRM3—nephrolithiasis	0.000208	0.000646	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.0002	0.000621	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PTH—nephrolithiasis	0.00019	0.000591	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000186	0.000579	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000186	0.000579	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000182	0.000565	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—APRT—nephrolithiasis	0.000182	0.000565	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—AQP1—nephrolithiasis	0.000176	0.000546	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—SPP1—nephrolithiasis	0.000171	0.000532	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—APRT—nephrolithiasis	0.00017	0.000528	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.00017	0.000528	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—SPP1—nephrolithiasis	0.000162	0.000503	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CHRM3—nephrolithiasis	0.000159	0.000494	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—AQP1—nephrolithiasis	0.000149	0.000462	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000148	0.00046	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—SPP1—nephrolithiasis	0.000139	0.000433	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—SPP1—nephrolithiasis	0.000138	0.000429	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CHRM3—nephrolithiasis	0.000134	0.000418	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—AQP1—nephrolithiasis	0.000133	0.000413	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000132	0.00041	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—AQP1—nephrolithiasis	0.00013	0.000403	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—SPP1—nephrolithiasis	0.000128	0.000397	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—SPP1—nephrolithiasis	0.000125	0.00039	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000121	0.000376	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CHRM3—nephrolithiasis	0.00012	0.000373	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—SPP1—nephrolithiasis	0.000119	0.00037	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—SPP1—nephrolithiasis	0.000119	0.000369	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000117	0.000364	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000112	0.000348	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000112	0.000348	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000109	0.00034	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—SPP1—nephrolithiasis	0.000107	0.000333	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—SPP1—nephrolithiasis	9.54e-05	0.000297	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AQP1—nephrolithiasis	7.98e-05	0.000248	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CHRM3—nephrolithiasis	7.22e-05	0.000224	CbGpPWpGaD
